| A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes (NCT01780272) | Novo Nordisk A/S | 2013-01-01 |
| A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc) (NCT01775761) | Pfizer | 2013-01-01 |
| Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (NCT02051387) | Central Institute of Mental Health, Mannheim | 2013-01-01 |
| To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01785433) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-01-01 |
| Safety and Feasibility Study of Targeted Temperature Management After ICH (NCT01607151) | Thomas Jefferson University | 2013-01-01 |
| ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects (NCT02949089) | Ache Laboratorios Farmaceuticos S.A. | 2013-01-01 |
| Glyburide Healthy Volunteer Study (NCT01716338) | Washington University School of Medicine | 2013-01-01 |
| Determining the Safety of L-serine in ALS (NCT01835782) | Phoenix Neurological Associates, LTD | 2013-01-01 |
| A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes (NCT01773798) | Novo Nordisk A/S | 2013-01-01 |
| Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function (NCT01766154) | Medicure | 2013-01-01 |
| Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori (NCT02803216) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2013-01-01 |
| Mesenchymal Stem Cells Enhanced With PRP Versus PRP In OA Knee (NCT01985633) | Aditya K Aggarwal | 2013-01-01 |
| Nicotine, Non-Smokers With and Without ADHD, and Genetics Study (NCT01819259) | Scott Kollins, PhD | 2013-01-01 |
| A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects (NCT01754116) | ViiV Healthcare | 2013-01-01 |
| Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart (NCT01782300) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| A Phase I Study of Oral UE2343 in Healthy Subjects (NCT01770886) | University of Edinburgh | 2013-01-01 |
| Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women (NCT01721993) | Thar Pharmaceuticals, Inc | 2013-01-01 |
| Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer (NCT01937689) | Jiangsu HengRui Medicine Co., Ltd. | 2013-01-01 |
| Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum (NCT01761123) | Vaxart | 2013-01-01 |
| Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis (NCT01745783) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2013-01-01 |
| Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation (NCT02779439) | University of Sydney | 2013-01-01 |
| Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT01737008) | University Health Network, Toronto | 2013-01-01 |
| Effects of Long-term Dry and Humidified Low-flow Oxygen Via Nasal Cannula (NCT02515786) | University of Sao Paulo | 2013-01-01 |
| Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease (NCT01747135) | Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company | 2013-01-01 |
| Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases (NCT01944930) | Lahey Clinic | 2013-01-01 |
| Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients (NCT02616822) | Hospital Universitario Pedro Ernesto | 2013-01-01 |
| Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma (NCT02145715) | Prof Jamie Cavenagh | 2013-01-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor (NCT01760343) | CSL Behring | 2013-01-01 |
| BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations (NCT01519323) | Hoffmann-La Roche | 2013-01-01 |
| Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) (NCT02759601) | Queen Mary University of London | 2013-01-01 |
| A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1 (NCT01739036) | University of Oxford | 2013-01-01 |
| Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation (NCT01736527) | Bausch & Lomb Incorporated | 2013-01-01 |
| Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma (NCT01700569) | Institut Cancerologie de l'Ouest | 2013-01-01 |
| A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults (NCT01779505) | Gilead Sciences | 2013-01-01 |
| CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01768897) | Wake Forest University Health Sciences | 2013-01-01 |
| Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients (NCT01741012) | Wayne State University | 2013-01-01 |
| Ibuprofen 5% Topical Gel CIPT (NCT01771822) | Pfizer | 2013-01-01 |
| Impact of Estrogen on Fear Extinction R61 (NCT02673606) | NYU Langone Health | 2013-01-01 |
| Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss (NCT02038972) | James Baumgartner, MD | 2013-01-01 |
| Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics (NCT01764750) | Washington University School of Medicine | 2013-01-01 |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. (NCT01730638) | Nantes University Hospital | 2013-01-01 |
| Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines (NCT01782066) | Leiden University Medical Center | 2013-01-01 |
| Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies (NCT01683149) | H. Lee Moffitt Cancer Center and Research Institute | 2013-01-01 |
| Functional Applications of Hyperpolarized 129Xe MRI (NCT01697332) | Brigham and Women's Hospital | 2013-01-01 |
| Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke (NCT01438593) | China Medical University Hospital | 2013-01-01 |
| Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004) (NCT01813513) | Merck Sharp & Dohme LLC | 2013-01-01 |
| Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence (NCT02052258) | MacDonald, Kai, M.D. | 2013-01-01 |
| Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension (NCT01987323) | Singapore Eye Research Institute | 2013-01-01 |
| A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus (NCT01818570) | Asbjørn Mohr Drewes | 2013-01-01 |
| Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study (NCT01865162) | Mid-Atlantic Epilepsy and Sleep Center, LLC | 2013-01-01 |
| Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (NCT01870037) | Urovant Sciences GmbH | 2013-01-01 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study (NCT02620618) | Cairo University | 2013-01-01 |
| Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study (NCT01768637) | University of Texas Southwestern Medical Center | 2013-01-01 |
| Meditation-CBT for Opioid-treated Chronic Low Back Pain (NCT01775995) | University of Wisconsin, Madison | 2013-01-01 |
| APG101 in Myelodysplastic Syndrome (NCT01736436) | Apogenix GmbH | 2013-01-01 |
| Study of Dasatinib, Androgen Deprivation Therapy and Radiation (NCT01826838) | Brown University | 2013-01-01 |
| C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation (NCT01759602) | Michael Levy | 2013-01-01 |
| Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease (NCT01791686) | Celldex Therapeutics | 2013-01-01 |
| A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects (NCT01768663) | Vertex Pharmaceuticals Incorporated | 2013-01-01 |
| Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses (NCT01756950) | Crucell Holland BV | 2013-01-01 |
| Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial (NCT01781637) | Boston Children's Hospital | 2013-01-01 |
| Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers (NCT01796899) | UCB Pharma SA | 2013-01-01 |
| Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin (NCT01767610) | Hanlim Pharm. Co., Ltd. | 2013-01-01 |
| Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer (NCT01774071) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets) (NCT01747083) | LG Life Sciences | 2013-01-01 |
| Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation (NCT01666769) | Kevin Watt | 2013-01-01 |
| Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury (NCT01769872) | R-Bio | 2013-01-01 |
| Impact of Formulation on Ciprofloxacin Oral Absorption (NCT00992329) | University of Maryland, Baltimore | 2013-01-01 |
| A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers (NCT01705275) | Ono Pharmaceutical Co., Ltd. | 2013-01-01 |
| Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission (NCT01603251) | London School of Hygiene and Tropical Medicine | 2013-01-01 |
| Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions (NCT01764945) | Boehringer Ingelheim | 2013-01-01 |
| A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects (NCT01754844) | AstraZeneca | 2013-01-01 |
| Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas (NCT01788189) | University Hospital, Essen | 2013-01-01 |
| Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium (NCT01775579) | Hanmi Pharmaceutical Company Limited | 2013-01-01 |
| Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) (NCT01500707) | Merck Sharp & Dohme LLC | 2013-01-01 |
| Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia (NCT01757119) | Pierre Fabre Medicament | 2013-01-01 |
| Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (NCT01732861) | Celgene | 2012-12-28 |
| A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants (NCT01762839) | Melinta Therapeutics, Inc. | 2012-12-27 |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma (NCT01723020) | Kartos Therapeutics, Inc. | 2012-12-27 |
| Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis (NCT01872026) | Astellas Pharma Inc | 2012-12-26 |
| A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370) (NCT01636960) | Merck Sharp & Dohme LLC | 2012-12-25 |
| A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003) (NCT01732510) | Merck Sharp & Dohme LLC | 2012-12-21 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (NCT01724814) | Hanmi Pharmaceutical Company Limited | 2012-12-20 |
| Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT01729845) | Fred Hutchinson Cancer Center | 2012-12-20 |
| BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) (NCT01750918) | Novartis Pharmaceuticals | 2012-12-19 |
| AZD1775 for Advanced Solid Tumors (NCT01748825) | National Cancer Institute (NCI) | 2012-12-19 |
| Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma (NCT01711528) | National Cancer Institute (NCI) | 2012-12-19 |
| A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis (NCT01730248) | Novartis Pharmaceuticals | 2012-12-18 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy (NCT01751776) | Boehringer Ingelheim | 2012-12-18 |
| Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer (NCT01596140) | M.D. Anderson Cancer Center | 2012-12-18 |
| Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL (NCT01752426) | M.D. Anderson Cancer Center | 2012-12-17 |
| Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma (NCT01645930) | Millennium Pharmaceuticals, Inc. | 2012-12-17 |
| Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma (NCT01542918) | James Rubenstein | 2012-12-17 |
| To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers (NCT01751074) | GlaxoSmithKline | 2012-12-17 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects (NCT01691547) | GlaxoSmithKline | 2012-12-17 |
| A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients (NCT01725802) | NeuroDerm Ltd. | 2012-12-16 |
| Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans (NCT01590277) | VA Office of Research and Development | 2012-12-14 |
| Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01757639) | National Cancer Institute (NCI) | 2012-12-14 |
| A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) (NCT01713582) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-12-14 |